Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px
Document › Details

Bayer AG. (9/11/12). "Press Release: New Drug Application for Bayer’s Regorafenib to Treat Patients with Colorectal Cancer Granted Priority Review in Japan [Not intended for U.S. and UK media]". Berlin.

Region Region Japan
Organisations Organisation Bayer Yakuhin Ltd.
  Group Bayer (Group)
  Organisation 2 Ministry of Health, Labor and Welfare (MHLW) (JP)
  Group Japan (govt)
Products Product regorafenib (BAY 73-4506)
  Product 2 clinical research
Person Person Malik, Kemal (Bayer 201402– Executive Board Member for Innovation joined Bayer 1995 before BMS UK)
     


   
Record changed: 2019-06-09

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

More documents for Bayer (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px




» top